Member Info for AquaeSulis01

The figure mentioned for bulk orders of ingredient was £20k per tonne. With 10 metric tonne ordered in April and another 10 metric tonne ordered in May at prices ranging between £20k and £30k per metric tonne if things continue in that vein then not unreasonable to expect revenue of £2.4M - £3.6M per annum

I have. US recorded sales of £202k for 2023 with the order from Muscletech accounting for £116k of it

$100k O think you'll find

I am expecting the financials for FY 2024 to disappoint but as TWealth has said it is now time to look forward and both Daily Nouri and DrMorepen look to be going spectacularly well with the latter a potential game changer for first gen products because slimbiome is finally front and centre of a planned weight management programme, so for the first time the outlook in the RNS may actually be credible.

https://lightlife360.in/?srsltid=AfmBOopuTMnO3SgzSXoG55VLgIHTiaLEaca6oJqn-KfZhGLSwJMK1iC9

Not commenting on whether selling sbtx is the best way of financing marketing and cash flow merely commenting on why SOH has decided to sell SBTX

Sells only going well with increased marketing spend and as not all Customers are prompt payers then lag between replenishing stock at cost and getting paid for it

PG, I think I might be reading different RNS's to you, from the Half Year Report "Acquisitions:

o Dermatonics fully integrated and performing as expected; Once Heel Balm being sold by Umesh Modi Group, starting with its home market in India.

o Bio-Tech Solutions (BTS) acquired for £1.25m in October 2024, adding manufacture and packaging of health, hygiene and personal care products, and a future development platform for topical products. Integration complete and performance in line with expectations."

So de-risked I would say.

Net, regarding the Pillars, each is a registered Company and as a relative newcomer to this Company it might be of benefit to you to watch the very first presentation at the link below to understand what the Pillars represent

https://www.skinbiotherapeutics.com/investor-relations/company-presentations/

Net, from the Mar 2022 half year report RNS "Croda has engaged with its VIP clients"

True Friedman but not forgetting the bigger Companies have had this ingredient for at least 2 years

Good spot net but not exactly prolific yet

Netcurtains, not even sure you have the year right. For instance, Luceane™ was launched by Sederma in Dec 2023 and still does not appear in a product for sale to the public that I can find. Catalyst will come one way or another when forward sells are revealed July I suspect rather than any public products containing zenakine appearing for sale.

https://www.sofw.com/en/products/product-launch-pad-en/57-personal-care/4211-sederma-launches-luceane-boost-cell-respiration-and-defensive-qi-for-a-healthy-skin-and-fresh-complexion

So the simple answer for shareholders like you who support the need to replace the current chair and NED's with more competent individuals is to pledge your support at this stage to force SOH's hand to take action himself with the safeguard that if SOH stubbornly refuses to act and it is likely to go to a vote with TW offered as a temporary alternative you at that stage abstain or switch allegiance at a vote

..insert "with replacements" after NED's

Lord, i think the analogy in this case is Trump rather than Farage. TW does not really want the Chairman role, what he is trying to do is demonstrate that he can gather sufficient votes to force SOH's hand to take action to remove the Chairman and current NED's who will better represent the interest of shareholders

I have also pledged my shares, one thing to sell SBTX shares to grow sells of Opti products through marketing but quite another to sell them prematurely when SOH by his own admission stated he didn't need to. More importantly, SOH is currently a single point of failure, should his health fail again or an accident befall him then the Chairman has already demonstrated he is incapable of stepping in to keep the Company fully functioning; witness the lack of communication to shareholders during SOH's prolonged hospital stay and the unanswered queries from Coca Cola

Mol means rebarm that slimbiome medical is an appetite suppressant shot rather than a meal replacement or snack bar. My guess is that medifast with their optavia range would be a good fit. https://www.optavia.com/us/en/optaviacategorypage/essential-shakes

Has it been clinically proven, is anyone buying it or is it at the same stage in its life cycle that skinbiotix was 6 years ago? Will it alter the plans of the VIPs who have had zenakine for the last 2 years ready for their respective launches or the flow of money already in the sbtx bank account? Don't think anyone will be losing too many by sleep at Croda

WILLG it is not the only solution the point is zenakine like the Swiss Army knife analogy used by SA can do the job of 4 or 5 different ingredients including boosting collagen naturally which is what makes it so unique and appealing

Think you need to read my post WIILG and perhaps do a little more research yourself

Just to add to a couple of elrico's listed comparator zenakine benefits:

"Peptides: Signal molecules for collagen/elastin synthesis, Limited to structural skin benefits."

Zenakine promotes the neosynthesis of extracellular matrix components, stimulating skin regeneration. At 3 %, it increases the production of: - Collagen I by 36 % * and collagen IV by 67 %* - Fibronectin by +20 %* and laminins by 26 %*

"Unlike traditional actives, Zenakine claims benefits such as improved sleep quality (+11.3% in 2 weeks), a more rested appearance, and increased happiness (+13.5% in 1 month), with 100% natural-origin content and full biodegradability."

Most significantly for anyone like me who struggles to reach deep sleep with 3 hrs unbroken sleep the norm

"Zenakine promotes restorative sleep after only 2 weeks of use."